Literature DB >> 27780657

Metabolic reprogramming & inflammation: Fuelling the host response to pathogens.

Laura E Gleeson1, Frederick J Sheedy2.   

Abstract

Successful immune responses to pathogens rely on efficient host innate processes to contain and limit bacterial growth, induce inflammatory response and promote antigen presentation for the development of adaptive immunity. This energy intensive process is regulated through multiple mechanisms including receptor-mediated signaling, control of phago-lysomal fusion events and promotion of bactericidal activities. Inherent macrophage activities therefore are dynamic and are modulated by signals and changes in the environment during infection. So too does the way these cells obtain their energy to adapt to altered homeostasis. It has emerged recently that the pathways employed by immune cells to derive energy from available or preferred nutrients underline the dynamic changes associated with immune activation. In particular, key breakpoints have been identified in the metabolism of glucose and lipids which direct not just how cells derive energy in the form of ATP, but also cellular phenotype and activation status. Much of this comes about through altered flux and accumulation of intermediate metabolites. How these changes in metabolism directly impact on the key processes required for anti-microbial immunity however, is less obvious. Here, we examine the 2 key nutrient utilization pathways employed by innate cells to fuel central energy metabolism and examine how these are altered in response to activation during infection, emphasising how certain metabolic switches or 'reprogramming' impacts anti-microbial processes. By examining carbohydrate and lipid pathways and how the flux of key intermediates intersects with innate immune signaling and the induction of bactericidal activities, we hope to illustrate the importance of these metabolic switches for protective immunity and provide a potential mechanism for how altered metabolic conditions in humans such as diabetes and hyperlipidemia alter the host response to infection.
Copyright © 2016. Published by Elsevier Ltd.

Entities:  

Keywords:  Diabetes; Glucose metabolism; Glycolytic reprogramming; Interleukin-1β Lipids; Macrophage; Mycobacterium tuberculosis; Trained immunity

Mesh:

Substances:

Year:  2016        PMID: 27780657     DOI: 10.1016/j.smim.2016.10.007

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   11.130


  16 in total

Review 1.  Immunometabolism: Another Road to Sepsis and Its Therapeutic Targeting.

Authors:  Vijay Kumar
Journal:  Inflammation       Date:  2019-06       Impact factor: 4.092

2.  Mitochondrial Damage and Activation of the STING Pathway Lead to Renal Inflammation and Fibrosis.

Authors:  Ki Wung Chung; Poonam Dhillon; Shizheng Huang; Xin Sheng; Rojesh Shrestha; Chengxiang Qiu; Brett A Kaufman; Jihwan Park; Liming Pei; Joseph Baur; Matthew Palmer; Katalin Susztak
Journal:  Cell Metab       Date:  2019-08-29       Impact factor: 27.287

Review 3.  A Metabolic Therapy for Malignant Glioma Requires a Clinical Measure.

Authors:  Zachary Corbin; Daniel Spielman; Lawrence Recht
Journal:  Curr Oncol Rep       Date:  2017-11-02       Impact factor: 5.075

Review 4.  Metabolic regulators of enigmatic inflammasomes in autoimmune diseases and crosstalk with innate immune receptors.

Authors:  Gisela Jimenez-Duran; Martha Triantafilou
Journal:  Immunology       Date:  2021-05-02       Impact factor: 7.397

5.  Plasma Pyruvate Kinase M2 as a marker of vascular inflammation in giant cell arteritis.

Authors:  Idil Esen; William F Jiemy; Yannick van Sleen; Johan Bijzet; Daniel M de Jong; Pieter H Nienhuis; Riemer H J A Slart; Peter Heeringa; Annemieke M H Boots; Elisabeth Brouwer
Journal:  Rheumatology (Oxford)       Date:  2022-07-06       Impact factor: 7.046

6.  Pneumolysin induced mitochondrial dysfunction leads to release of mitochondrial DNA.

Authors:  Andreas Nerlich; Maren Mieth; Eleftheria Letsiou; Diana Fatykhova; Katja Zscheppang; Aki Imai-Matsushima; Thomas F Meyer; Lisa Paasch; Timothy J Mitchell; Mario Tönnies; Torsten T Bauer; Paul Schneider; Jens Neudecker; Jens C Rückert; Stephan Eggeling; Maria Schimek; Martin Witzenrath; Norbert Suttorp; Stefan Hippenstiel; Andreas C Hocke
Journal:  Sci Rep       Date:  2018-01-09       Impact factor: 4.379

7.  The Hydroalcoholic Extract Obtained from Mentha piperita L. Leaves Attenuates Oxidative Stress and Improves Survival in Lipopolysaccharide-Treated Macrophages.

Authors:  Mariana Oliveira Arruda; Saulo José Figueiredo Mendes; Simone Aparecida Teixeira; Ludmilla Santos Silva de Mesquita; Maria Nilce de Sousa Ribeiro; Stanley de Sousa Lima Galvão; Marcelo Nicolás Muscará; Elizabeth Soares Fernandes; Valério Monteiro-Neto
Journal:  J Immunol Res       Date:  2017-09-20       Impact factor: 4.818

Review 8.  Innate Immune Function of Mitochondrial Metabolism.

Authors:  David Sancho; Michel Enamorado; Johan Garaude
Journal:  Front Immunol       Date:  2017-05-08       Impact factor: 7.561

9.  Type I interferon decreases macrophage energy metabolism during mycobacterial infection.

Authors:  Gregory S Olson; Tara A Murray; Ana N Jahn; Dat Mai; Alan H Diercks; Elizabeth S Gold; Alan Aderem
Journal:  Cell Rep       Date:  2021-06-01       Impact factor: 9.423

Review 10.  The cell biology of inflammation: From common traits to remarkable immunological adaptations.

Authors:  Helen Weavers; Paul Martin
Journal:  J Cell Biol       Date:  2020-07-06       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.